Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Key findings at the highest dose (12mg weekly): Up to 24% mean body weight reduction over 48 weeks Significant reductions in fasting glucose and insulin resistance markers Meaningful reductions in liver fat content, relevant for participants with metabolic-associated fatty liver disease Once-weekly subcutaneous dosing was generally well-tolerated For context, semaglutide at its approved dose achieves approximately 1517% body weight reduction over 68 weeks
Behavioral strategiesincluding structured meal planning, mindful eating practices, and postpartum exercise progressionremain the foundation of weight management throughout pregnancy and the postpartum period
Cardiometabolic Profiles of Oral and Subcutaneous Glucagon-Like Peptide-1 Receptor Mono-Agonists in Adults With Overweight or Obesity: A Systematic Review and Network Meta-Analysis
This freeze-drying process removes moisture while preserving the delicate peptide structure, resulting in a white to off-white powder that requires careful reconstitution before use
Since appetite is significantly reduced, this can be difficult to achieve without intentional meal planning
